Results for tag: "Hospital Acquired Infection Control"

The Hospital Acquired Infection Control market is a subset of the Infectious Diseases Drugs market, focusing on the prevention and treatment of infections acquired in a hospital setting. This includes a range of drugs, such as antibiotics, antivirals, antifungals, and antiparasitics, as well as other treatments such as vaccines and immunoglobulins. The market is driven by the need to reduce the risk of infection in hospitals, as well as the increasing prevalence of antibiotic-resistant bacteria. The market is highly competitive, with a range of large and small companies offering products and services. Major players include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Johnson & Johnson. Other companies in the market include AstraZeneca, Novartis, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more